APO Research, Inc.
Talk to an analyst

APO RESEARCH · REPORT

Glutamate Carboxypeptidase 2

Compare research editions
View pricing & licenses

Selected research

Market Outlook & Growth Opportunities

Global Glutamate Carboxypeptidase 2 Market Outlook and Growth Opportunities 2026

Report ID 173995720419 December 2025193 pages

Choose your research edition.

Industry ResearchGlutamate Carboxypeptidase 2 Industry Research Report 2026106 pages · $2,950 USDIndustry Growth & TrendsGlobal Glutamate Carboxypeptidase 2 Industry Growth and Trends Forecast to 203273 pages · $3,450 USDMarket StructureGlobal Glutamate Carboxypeptidase 2 Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032172 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Glutamate Carboxypeptidase 2 Market Outlook and Growth Opportunities 2026193 pages · $4,250 USDMarket Analysis & ForecastGlobal Glutamate Carboxypeptidase 2 Market Analysis and Forecast 2026-2032190 pages · $4,950 USD

Market perspective

The global Glutamate Carboxypeptidase 2 market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a compound annual growth rate (CAGR) of % over 2026-2032.

The North America market for Glutamate Carboxypeptidase 2 is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Glutamate Carboxypeptidase 2 is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Glutamate Carboxypeptidase 2 is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

In China, the Glutamate Carboxypeptidase 2 market is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Major global companies in the Glutamate Carboxypeptidase 2 market include Eisai Co Ltd, Inovio Pharmaceuticals Inc, Crescendo Biologics Ltd and Cerecor Inc, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global Glutamate Carboxypeptidase 2 market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Glutamate Carboxypeptidase 2 and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Glutamate Carboxypeptidase 2 sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Glutamate Carboxypeptidase 2 market size, projected growth trends, production technologies, key applications, and end-use industries.

Glutamate Carboxypeptidase 2 Segment by Company

Eisai Co Ltd

Inovio Pharmaceuticals Inc

Crescendo Biologics Ltd

Cerecor Inc

Glutamate Carboxypeptidase 2 Segment by Type

INO-5150

E-2072

Others

Glutamate Carboxypeptidase 2 Segment by Application

Glioblastoma Multiforme

Congnitive Impairment

Prostate Cancer

Neuropathic Pain

Others

Glutamate Carboxypeptidase 2 Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Middle East & Africa

Turkey

Saudi Arabia

UAE

Study Objectives

1. To analyze and research the global Glutamate Carboxypeptidase 2 status and future forecast, involving, sales, revenue, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions Glutamate Carboxypeptidase 2 market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify Glutamate Carboxypeptidase 2 significant trends, drivers, influence factors in global and regions.

6. To analyze Glutamate Carboxypeptidase 2 competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Glutamate Carboxypeptidase 2 market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Glutamate Carboxypeptidase 2 and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Glutamate Carboxypeptidase 2.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Glutamate Carboxypeptidase 2 market, including product definition, global market growth prospects, sales value, sales volume, and average price forecasts (2021-2032).

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Glutamate Carboxypeptidase 2 industry.

Chapter 3: Detailed analysis of Glutamate Carboxypeptidase 2 manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales and value of Glutamate Carboxypeptidase 2 in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.

Chapter 7: Sales and value of Glutamate Carboxypeptidase 2 in country level. It provides sigmate data by type, and by application for each country/region.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights.

More report detail

Tables and figures
List of Tables Table 1. Glutamate Carboxypeptidase 2 Industry Trends Table 2. Glutamate Carboxypeptidase 2 Industry Drivers Table 3. Glutamate Carboxypeptidase 2 Industry Opportunities and Challenges Table 4. Glutamate Carboxypeptidase 2 Industry Restraints Table 5. Global Glutamate Carboxypeptidase 2 Revenue by Company (US$ Million) & (2021-2026) Table 6. Global Glutamate Carboxypeptidase 2 Revenue Share by Company (2021-2026) Table 7. Global Glutamate Carboxypeptidase 2 Sales Volume by Company (K Units) & (2021-2026) Table 8. Global Glutamate Carboxypeptidase 2 Sales Volume Share by Company (2021-2026) Table 9. Global Glutamate Carboxypeptidase 2 Average Price (US$/Unit) of Company (2021-2026) Table 10. Global Glutamate Carboxypeptidase 2 Company Ranking, (2024-2026) & (USD Million) Table 11. Global Glutamate Carboxypeptidase 2 Key Company Manufacturing Base & Headquarters Table 12. Global Glutamate Carboxypeptidase 2 Company, Product Type & Application Table 13. Global Glutamate Carboxypeptidase 2 Company Establishment Date Table 14. Global Company Market Concentration Ratio (CR5 and HHI) Table 15. Global Glutamate Carboxypeptidase 2 by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025) Table 16. Mergers & Acquisitions, Expansion Table 17. Significant Companies of INO-5150 Table 18. Significant Companies of E-2072 Table 19. Significant Companies of Others Table 20. Global Glutamate Carboxypeptidase 2 Sales Volume by Type 2021 VS 2025 VS 2032 (K Units) Table 21. Global Glutamate Carboxypeptidase 2 Sales Volume by Type (2021-2026) & (K Units) Table 22. Global Glutamate Carboxypeptidase 2 Sales Volume by Type (2027-2032) & (K Units) Table 23. Global Glutamate Carboxypeptidase 2 Sales Volume Share by Type (2021-2026) Table 24. Global Glutamate Carboxypeptidase 2 Sales Volume Share by Type (2027-2032) Table 25. Global Glutamate Carboxypeptidase 2 Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million) Table 26. Global Glutamate Carboxypeptidase 2 Sales Value by Type (2021-2026) & (US$ Million) Table 27. Global Glutamate Carboxypeptidase 2 Sales Value by Type (2027-2032) & (US$ Million) Table 28. Global Glutamate Carboxypeptidase 2 Sales Value Share by Type (2021-2026) Table 29. Global Glutamate Carboxypeptidase 2 Sales Value Share by Type (2027-2032) Table 30. Significant Companies of Glioblastoma Multiforme Table 31. Significant Companies of Congnitive Impairment Table 32. Significant Companies of Prostate Cancer Table 33. Significant Companies of Neuropathic Pain Table 34. Significant Companies of Others Table 35. Global Glutamate Carboxypeptidase 2 Sales Volume by Application 2021 VS 2025 VS 2032 (K Units) Table 36. Global Glutamate Carboxypeptidase 2 Sales Volume by Application (2021-2026) & (K Units) Table 37. Global Glutamate Carboxypeptidase 2 Sales Volume by Application (2027-2032) & (K Units) Table 38. Global Glutamate Carboxypeptidase 2 Sales Volume Share by Application (2021-2026) Table 39. Global Glutamate Carboxypeptidase 2 Sales Volume Share by Application (2027-2032) Table 40. Global Glutamate Carboxypeptidase 2 Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million) Table 41. Global Glutamate Carboxypeptidase 2 Sales Value by Application (2021-2026) & (US$ Million) Table 42. Global Glutamate Carboxypeptidase 2 Sales Value by Application (2027-2032) & (US$ Million) Table 43. Global Glutamate Carboxypeptidase 2 Sales Value Share by Application (2021-2026) Table 44. Global Glutamate Carboxypeptidase 2 Sales Value Share by Application (2027-2032) Table 45. Global Glutamate Carboxypeptidase 2 Sales by Region: 2021 VS 2025 VS 2032 (K Units) Table 46. Global Glutamate Carboxypeptidase 2 Sales by Region (2021-2026) & (K Units) Table 47. Global Glutamate Carboxypeptidase 2 Sales Market Share by Region (2021-2026) Table 48. Global Glutamate Carboxypeptidase 2 Sales by Region (2027-2032) & (K Units) Table 49. Global Glutamate Carboxypeptidase 2 Sales Market Share by Region (2027-2032) Table 50. Global Glutamate Carboxypeptidase 2 Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 51. Global Glutamate Carboxypeptidase 2 Sales Value by Region (2021-2026) & (US$ Million) Table 52. Global Glutamate Carboxypeptidase 2 Sales Value Share by Region (2021-2026) Table 53. Global Glutamate Carboxypeptidase 2 Sales Value by Region (2027-2032) & (US$ Million) Table 54. Global Glutamate Carboxypeptidase 2 Sales Value Share by Region (2027-2032) Table 55. Global Glutamate Carboxypeptidase 2 Market Average Price (US$/Unit) by Region (2021-2026) Table 56. Global Glutamate Carboxypeptidase 2 Market Average Price (US$/Unit) by Region (2027-2032) Table 57. Global Glutamate Carboxypeptidase 2 Sales by Country: 2021 VS 2025 VS 2032 (K Units) Table 58. Global Glutamate Carboxypeptidase 2 Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 59. Global Glutamate Carboxypeptidase 2 Sales by Country (2021-2026) & (K Units) Table 60. Global Glutamate Carboxypeptidase 2 Sales Market Share by Country (2021-2026) Table 61. Global Glutamate Carboxypeptidase 2 Sales by Country (2027-2032) & (K Units) Table 62. Global Glutamate Carboxypeptidase 2 Sales Market Share by Country (2027-2032) Table 63. Global Glutamate Carboxypeptidase 2 Sales Value by Country (2021-2026) & (US$ Million) Table 64. Global Glutamate Carboxypeptidase 2 Sales Value Market Share by Country (2021-2026) Table 65. Global Glutamate Carboxypeptidase 2 Sales Value by Country (2027-2032) & (US$ Million) Table 66. Global Glutamate Carboxypeptidase 2 Sales Value Market Share by Country (2027-2032) Table 67. Eisai Co Ltd Company Information Table 68. Eisai Co Ltd Business Overview Table 69. Eisai Co Ltd Glutamate Carboxypeptidase 2 Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 70. Eisai Co Ltd Glutamate Carboxypeptidase 2 Product Portfolio Table 71. Eisai Co Ltd Recent Development Table 72. Inovio Pharmaceuticals Inc Company Information Table 73. Inovio Pharmaceuticals Inc Business Overview Table 74. Inovio Pharmaceuticals Inc Glutamate Carboxypeptidase 2 Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 75. Inovio Pharmaceuticals Inc Glutamate Carboxypeptidase 2 Product Portfolio Table 76. Inovio Pharmaceuticals Inc Recent Development Table 77. Crescendo Biologics Ltd Company Information Table 78. Crescendo Biologics Ltd Business Overview Table 79. Crescendo Biologics Ltd Glutamate Carboxypeptidase 2 Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 80. Crescendo Biologics Ltd Glutamate Carboxypeptidase 2 Product Portfolio Table 81. Crescendo Biologics Ltd Recent Development Table 82. Cerecor Inc Company Information Table 83. Cerecor Inc Business Overview Table 84. Cerecor Inc Glutamate Carboxypeptidase 2 Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 85. Cerecor Inc Glutamate Carboxypeptidase 2 Product Portfolio Table 86. Cerecor Inc Recent Development Table 87. Key Raw Materials Table 88. Raw Materials Key Suppliers Table 89. Glutamate Carboxypeptidase 2 Distributors List Table 90. Glutamate Carboxypeptidase 2 Customers List Table 91. Research Programs/Design for This Report Table 92. Authors List of This Report Table 93. Secondary Sources Table 94. Primary Sources List of Figures Figure 1. Glutamate Carboxypeptidase 2 Product Image Figure 2. Global Glutamate Carboxypeptidase 2 Sales Value (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Glutamate Carboxypeptidase 2 Sales Value (2021-2032) & (US$ Million) Figure 4. Global Glutamate Carboxypeptidase 2 Sales (2021-2032) & (K Units) Figure 5. Global Glutamate Carboxypeptidase 2 Sales Average Price (US$/Unit) & (2021-2032) Figure 6. Global Glutamate Carboxypeptidase 2 Company Revenue Ranking in 2025 (US$ Million) Figure 7. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million) Figure 8. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 9. INO-5150 Image Figure 10. E-2072 Image Figure 11. Others Image Figure 12. Global Glutamate Carboxypeptidase 2 Sales Volume by Type (2021 VS 2025 VS 2032) & (K Units) Figure 13. Global Glutamate Carboxypeptidase 2 Sales Volume Share 2021 VS 2025 VS 2032 Figure 14. Global Glutamate Carboxypeptidase 2 Sales Volume Share by Type (2021-2032) Figure 15. Global Glutamate Carboxypeptidase 2 Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 16. Global Glutamate Carboxypeptidase 2 Sales Value Share 2021 VS 2025 VS 2032 Figure 17. Global Glutamate Carboxypeptidase 2 Sales Value Share by Type (2021-2032) Figure 18. Glioblastoma Multiforme Image Figure 19. Congnitive Impairment Image Figure 20. Prostate Cancer Image Figure 21. Neuropathic Pain Image Figure 22. Others Image Figure 23. Global Glutamate Carboxypeptidase 2 Sales Volume by Application (2021 VS 2025 VS 2032) & (K Units) Figure 24. Global Glutamate Carboxypeptidase 2 Sales Volume Share 2021 VS 2025 VS 2032 Figure 25. Global Glutamate Carboxypeptidase 2 Sales Volume Share by Application (2021-2032) Figure 26. Global Glutamate Carboxypeptidase 2 Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 27. Global Glutamate Carboxypeptidase 2 Sales Value Share 2021 VS 2025 VS 2032 Figure 28. Global Glutamate Carboxypeptidase 2 Sales Value Share by Application (2021-2032) Figure 29. Global Glutamate Carboxypeptidase 2 Sales by Region: 2021 VS 2025 VS 2032 (K Units) Figure 30. Global Glutamate Carboxypeptidase 2 Sales Market Share by Region: 2021 VS 2025 VS 2032 Figure 31. Global Glutamate Carboxypeptidase 2 Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 32. Global Glutamate Carboxypeptidase 2 Sales Value Share by Region: 2021 VS 2025 VS 2032 Figure 33. North America Glutamate Carboxypeptidase 2 Sales Value (2021-2032) & (US$ Million) Figure 34. North America Glutamate Carboxypeptidase 2 Sales Value Share by Country (%), 2025 VS 2032 Figure 35. Europe Glutamate Carboxypeptidase 2 Sales Value (2021-2032) & (US$ Million) Figure 36. Europe Glutamate Carboxypeptidase 2 Sales Value Share by Country (%), 2025 VS 2032 Figure 37. Asia-Pacific Glutamate Carboxypeptidase 2 Sales Value (2021-2032) & (US$ Million) Figure 38. Asia-Pacific Glutamate Carboxypeptidase 2 Sales Value Share by Country (%), 2025 VS 2032 Figure 39. South America Glutamate Carboxypeptidase 2 Sales Value (2021-2032) & (US$ Million) Figure 40. South America Glutamate Carboxypeptidase 2 Sales Value Share by Country (%), 2025 VS 2032 Figure 41. Middle East & Africa Glutamate Carboxypeptidase 2 Sales Value (2021-2032) & (US$ Million) Figure 42. Middle East & Africa Glutamate Carboxypeptidase 2 Sales Value Share by Country (%), 2025 VS 2032 Figure 43. USA Glutamate Carboxypeptidase 2 Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 44. USA Glutamate Carboxypeptidase 2 Sales Value Share by Type, 2025 VS 2032 & (%) Figure 45. USA Glutamate Carboxypeptidase 2 Sales Value Share by Application, 2025 VS 2032 & (%) Figure 46. Canada Glutamate Carboxypeptidase 2 Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 47. Canada Glutamate Carboxypeptidase 2 Sales Value Share by Type, 2025 VS 2032 & (%) Figure 48. Canada Glutamate Carboxypeptidase 2 Sales Value Share by Application, 2025 VS 2032 & (%) Figure 49. Mexico Glutamate Carboxypeptidase 2 Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 50. Mexico Glutamate Carboxypeptidase 2 Sales Value Share by Type, 2025 VS 2032 & (%) Figure 51. Mexico Glutamate Carboxypeptidase 2 Sales Value Share by Application, 2025 VS 2032 & (%) Figure 52. Germany Glutamate Carboxypeptidase 2 Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 53. Germany Glutamate Carboxypeptidase 2 Sales Value Share by Type, 2025 VS 2032 & (%) Figure 54. Germany Glutamate Carboxypeptidase 2 Sales Value Share by Application, 2025 VS 2032 & (%) Figure 55. France Glutamate Carboxypeptidase 2 Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 56. France Glutamate Carboxypeptidase 2 Sales Value Share by Type, 2025 VS 2032 & (%) Figure 57. France Glutamate Carboxypeptidase 2 Sales Value Share by Application, 2025 VS 2032 & (%) Figure 58. U.K. Glutamate Carboxypeptidase 2 Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 59. U.K. Glutamate Carboxypeptidase 2 Sales Value Share by Type, 2025 VS 2032 & (%) Figure 60. U.K. Glutamate Carboxypeptidase 2 Sales Value Share by Application, 2025 VS 2032 & (%) Figure 61. Italy Glutamate Carboxypeptidase 2 Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 62. Italy Glutamate Carboxypeptidase 2 Sales Value Share by Type, 2025 VS 2032 & (%) Figure 63. Italy Glutamate Carboxypeptidase 2 Sales Value Share by Application, 2025 VS 2032 & (%) Figure 64. Spain Glutamate Carboxypeptidase 2 Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 65. Spain Glutamate Carboxypeptidase 2 Sales Value Share by Type, 2025 VS 2032 & (%) Figure 66. Spain Glutamate Carboxypeptidase 2 Sales Value Share by Application, 2025 VS 2032 & (%) Figure 67. Russia Glutamate Carboxypeptidase 2 Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 68. Russia Glutamate Carboxypeptidase 2 Sales Value Share by Type, 2025 VS 2032 & (%) Figure 69. Russia Glutamate Carboxypeptidase 2 Sales Value Share by Application, 2025 VS 2032 & (%) Figure 70. Netherlands Glutamate Carboxypeptidase 2 Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 71. Netherlands Glutamate Carboxypeptidase 2 Sales Value Share by Type, 2025 VS 2032 & (%) Figure 72. Netherlands Glutamate Carboxypeptidase 2 Sales Value Share by Application, 2025 VS 2032 & (%) Figure 73. Nordic Countries Glutamate Carboxypeptidase 2 Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 74. Nordic Countries Glutamate Carboxypeptidase 2 Sales Value Share by Type, 2025 VS 2032 & (%) Figure 75. Nordic Countries Glutamate Carboxypeptidase 2 Sales Value Share by Application, 2025 VS 2032 & (%) Figure 76. China Glutamate Carboxypeptidase 2 Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 77. China Glutamate Carboxypeptidase 2 Sales Value Share by Type, 2025 VS 2032 & (%) Figure 78. China Glutamate Carboxypeptidase 2 Sales Value Share by Application, 2025 VS 2032 & (%) Figure 79. Japan Glutamate Carboxypeptidase 2 Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 80. Japan Glutamate Carboxypeptidase 2 Sales Value Share by Type, 2025 VS 2032 & (%) Figure 81. Japan Glutamate Carboxypeptidase 2 Sales Value Share by Application, 2025 VS 2032 & (%) Figure 82. South Korea Glutamate Carboxypeptidase 2 Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 83. South Korea Glutamate Carboxypeptidase 2 Sales Value Share by Type, 2025 VS 2032 & (%) Figure 84. South Korea Glutamate Carboxypeptidase 2 Sales Value Share by Application, 2025 VS 2032 & (%) Figure 85. India Glutamate Carboxypeptidase 2 Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 86. India Glutamate Carboxypeptidase 2 Sales Value Share by Type, 2025 VS 2032 & (%) Figure 87. India Glutamate Carboxypeptidase 2 Sales Value Share by Application, 2025 VS 2032 & (%) Figure 88. Australia Glutamate Carboxypeptidase 2 Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 89. Australia Glutamate Carboxypeptidase 2 Sales Value Share by Type, 2025 VS 2032 & (%) Figure 90. Australia Glutamate Carboxypeptidase 2 Sales Value Share by Application, 2025 VS 2032 & (%) Figure 91. Southeast Asia Glutamate Carboxypeptidase 2 Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 92. Southeast Asia Glutamate Carboxypeptidase 2 Sales Value Share by Type, 2025 VS 2032 & (%) Figure 93. Southeast Asia Glutamate Carboxypeptidase 2 Sales Value Share by Application, 2025 VS 2032 & (%) Figure 94. Brazil Glutamate Carboxypeptidase 2 Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 95. Brazil Glutamate Carboxypeptidase 2 Sales Value Share by Type, 2025 VS 2032 & (%) Figure 96. Brazil Glutamate Carboxypeptidase 2 Sales Value Share by Application, 2025 VS 2032 & (%) Figure 97. Argentina Glutamate Carboxypeptidase 2 Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 98. Argentina Glutamate Carboxypeptidase 2 Sales Value Share by Type, 2025 VS 2032 & (%) Figure 99. Argentina Glutamate Carboxypeptidase 2 Sales Value Share by Application, 2025 VS 2032 & (%) Figure 100. Chile Glutamate Carboxypeptidase 2 Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 101. Chile Glutamate Carboxypeptidase 2 Sales Value Share by Type, 2025 VS 2032 & (%) Figure 102. Chile Glutamate Carboxypeptidase 2 Sales Value Share by Application, 2025 VS 2032 & (%) Figure 103. Colombia Glutamate Carboxypeptidase 2 Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 104. Colombia Glutamate Carboxypeptidase 2 Sales Value Share by Type, 2025 VS 2032 & (%) Figure 105. Colombia Glutamate Carboxypeptidase 2 Sales Value Share by Application, 2025 VS 2032 & (%) Figure 106. Peru Glutamate Carboxypeptidase 2 Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 107. Peru Glutamate Carboxypeptidase 2 Sales Value Share by Type, 2025 VS 2032 & (%) Figure 108. Peru Glutamate Carboxypeptidase 2 Sales Value Share by Application, 2025 VS 2032 & (%) Figure 109. Saudi Arabia Glutamate Carboxypeptidase 2 Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 110. Saudi Arabia Glutamate Carboxypeptidase 2 Sales Value Share by Type, 2025 VS 2032 & (%) Figure 111. Saudi Arabia Glutamate Carboxypeptidase 2 Sales Value Share by Application, 2025 VS 2032 & (%) Figure 112. Israel Glutamate Carboxypeptidase 2 Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 113. Israel Arabia Glutamate Carboxypeptidase 2 Sales Value Share by Type, 2025 VS 2032 & (%) Figure 114. Israel Arabia Glutamate Carboxypeptidase 2 Sales Value Share by Application, 2025 VS 2032 & (%) Figure 115. UAE Glutamate Carboxypeptidase 2 Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 116. UAE Glutamate Carboxypeptidase 2 Sales Value Share by Type, 2025 VS 2032 & (%) Figure 117. UAE Glutamate Carboxypeptidase 2 Sales Value Share by Application, 2025 VS 2032 & (%) Figure 118. Turkey Glutamate Carboxypeptidase 2 Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 119. Turkey Glutamate Carboxypeptidase 2 Sales Value Share by Type, 2025 VS 2032 & (%) Figure 120. Turkey Glutamate Carboxypeptidase 2 Sales Value Share by Application, 2025 VS 2032 & (%) Figure 121. Iran Glutamate Carboxypeptidase 2 Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 122. Iran Glutamate Carboxypeptidase 2 Sales Value Share by Type, 2025 VS 2032 & (%) Figure 123. Iran Glutamate Carboxypeptidase 2 Sales Value Share by Application, 2025 VS 2032 & (%) Figure 124. Egypt Glutamate Carboxypeptidase 2 Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 125. Egypt Glutamate Carboxypeptidase 2 Sales Value Share by Type, 2025 VS 2032 & (%) Figure 126. Egypt Glutamate Carboxypeptidase 2 Sales Value Share by Application, 2025 VS 2032 & (%) Figure 127. Glutamate Carboxypeptidase 2 Value Chain Figure 128. Manufacturing Cost Structure Figure 129. Glutamate Carboxypeptidase 2 Sales Mode & Process Figure 130. Direct Comparison with Distribution Share Figure 131. Distributors Profiles Figure 132. Years Considered Figure 133. Research Process Figure 134. Key Executives Interviewed

Scope & coverage.

Types
  • INO-5150
  • E-2072
  • Others
Applications
  • Glioblastoma Multiforme
  • Congnitive Impairment
  • Prostate Cancer
  • Neuropathic Pain
  • Others
Companies covered
  • Eisai Co Ltd
  • Inovio Pharmaceuticals Inc
  • Crescendo Biologics Ltd
  • Cerecor Inc

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Glutamate Carboxypeptidase 2 Sales Value (2021-2032)
  4. 1.2.2 Global Glutamate Carboxypeptidase 2 Sales Volume (2021-2032)
  5. 1.2.3 Global Glutamate Carboxypeptidase 2 Sales Average Price (2021-2032)
  6. 1.3 Assumptions and Limitations
  7. 1.4 Study Goals and Objectives
2 Glutamate Carboxypeptidase 2 Market Dynamics
  1. 2.1 Glutamate Carboxypeptidase 2 Industry Trends
  2. 2.2 Glutamate Carboxypeptidase 2 Industry Drivers
  3. 2.3 Glutamate Carboxypeptidase 2 Industry Opportunities and Challenges
  4. 2.4 Glutamate Carboxypeptidase 2 Industry Restraints
3 Glutamate Carboxypeptidase 2 Market by Company
  1. 3.1 Global Glutamate Carboxypeptidase 2 Company Revenue Ranking in 2025
  2. 3.2 Global Glutamate Carboxypeptidase 2 Revenue by Company (2021-2026)
  3. 3.3 Global Glutamate Carboxypeptidase 2 Sales Volume by Company (2021-2026)
  4. 3.4 Global Glutamate Carboxypeptidase 2 Average Price by Company (2021-2026)
  5. 3.5 Global Glutamate Carboxypeptidase 2 Company Ranking (2024-2026)
  6. 3.6 Global Glutamate Carboxypeptidase 2 Company Manufacturing Base and Headquarters
  7. 3.7 Global Glutamate Carboxypeptidase 2 Company Product Type and Application
  8. 3.8 Global Glutamate Carboxypeptidase 2 Company Establishment Date
  9. 3.9 Market Competitive Analysis
  10. 3.9.1 Global Glutamate Carboxypeptidase 2 Market Concentration Ratio (CR5 and HHI)
  11. 3.9.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
  12. 3.9.3 2025 Glutamate Carboxypeptidase 2 Tier 1, Tier 2, and Tier 3 Companies
  13. 3.10 Mergers and Acquisitions Expansion
4 Glutamate Carboxypeptidase 2 Market by Type
  1. 4.1 Glutamate Carboxypeptidase 2 Type Introduction
  2. 4.1.1 INO-5150
  3. 4.1.2 E-2072
  4. 4.1.3 Others
  5. 4.2 Global Glutamate Carboxypeptidase 2 Sales Volume by Type
  6. 4.2.1 Global Glutamate Carboxypeptidase 2 Sales Volume by Type (2021 VS 2025 VS 2032)
  7. 4.2.2 Global Glutamate Carboxypeptidase 2 Sales Volume by Type (2021-2032)
  8. 4.2.3 Global Glutamate Carboxypeptidase 2 Sales Volume Share by Type (2021-2032)
  9. 4.3 Global Glutamate Carboxypeptidase 2 Sales Value by Type
  10. 4.3.1 Global Glutamate Carboxypeptidase 2 Sales Value by Type (2021 VS 2025 VS 2032)
  11. 4.3.2 Global Glutamate Carboxypeptidase 2 Sales Value by Type (2021-2032)
  12. 4.3.3 Global Glutamate Carboxypeptidase 2 Sales Value Share by Type (2021-2032)
5 Glutamate Carboxypeptidase 2 Market by Application
  1. 5.1 Glutamate Carboxypeptidase 2 Application Introduction
  2. 5.1.1 Glioblastoma Multiforme
  3. 5.1.2 Congnitive Impairment
  4. 5.1.3 Prostate Cancer
  5. 5.1.4 Neuropathic Pain
  6. 5.1.5 Others
  7. 5.2 Global Glutamate Carboxypeptidase 2 Sales Volume by Application
  8. 5.2.1 Global Glutamate Carboxypeptidase 2 Sales Volume by Application (2021 VS 2025 VS 2032)
  9. 5.2.2 Global Glutamate Carboxypeptidase 2 Sales Volume by Application (2021-2032)
  10. 5.2.3 Global Glutamate Carboxypeptidase 2 Sales Volume Share by Application (2021-2032)
  11. 5.3 Global Glutamate Carboxypeptidase 2 Sales Value by Application
  12. 5.3.1 Global Glutamate Carboxypeptidase 2 Sales Value by Application (2021 VS 2025 VS 2032)
  13. 5.3.2 Global Glutamate Carboxypeptidase 2 Sales Value by Application (2021-2032)
  14. 5.3.3 Global Glutamate Carboxypeptidase 2 Sales Value Share by Application (2021-2032)
6 Glutamate Carboxypeptidase 2 Regional Sales and Value Analysis
  1. 6.1 Global Glutamate Carboxypeptidase 2 Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Glutamate Carboxypeptidase 2 Sales by Region (2021-2032)
  3. 6.2.1 Global Glutamate Carboxypeptidase 2 Sales by Region: 2021-2026
  4. 6.2.2 Global Glutamate Carboxypeptidase 2 Sales by Region (2027-2032)
  5. 6.3 Global Glutamate Carboxypeptidase 2 Sales Value by Region: 2021 VS 2025 VS 2032
  6. 6.4 Global Glutamate Carboxypeptidase 2 Sales Value by Region (2021-2032)
  7. 6.4.1 Global Glutamate Carboxypeptidase 2 Sales Value by Region: 2021-2026
  8. 6.4.2 Global Glutamate Carboxypeptidase 2 Sales Value by Region (2027-2032)
  9. 6.5 Global Glutamate Carboxypeptidase 2 Market Price Analysis by Region (2021-2026)
  10. 6.6 North America
  11. 6.6.1 North America Glutamate Carboxypeptidase 2 Sales Value (2021-2032)
  12. 6.6.2 North America Glutamate Carboxypeptidase 2 Sales Value Share by Country, 2025 VS 2032
  13. 6.7 Europe
  14. 6.7.1 Europe Glutamate Carboxypeptidase 2 Sales Value (2021-2032)
  15. 6.7.2 Europe Glutamate Carboxypeptidase 2 Sales Value Share by Country, 2025 VS 2032
  16. 6.8 Asia-Pacific
  17. 6.8.1 Asia-Pacific Glutamate Carboxypeptidase 2 Sales Value (2021-2032)
  18. 6.8.2 Asia-Pacific Glutamate Carboxypeptidase 2 Sales Value Share by Country, 2025 VS 2032
  19. 6.9 South America
  20. 6.9.1 South America Glutamate Carboxypeptidase 2 Sales Value (2021-2032)
  21. 6.9.2 South America Glutamate Carboxypeptidase 2 Sales Value Share by Country, 2025 VS 2032
  22. 6.10 Middle East & Africa
  23. 6.10.1 Middle East & Africa Glutamate Carboxypeptidase 2 Sales Value (2021-2032)
  24. 6.10.2 Middle East & Africa Glutamate Carboxypeptidase 2 Sales Value Share by Country, 2025 VS 2032
7 Glutamate Carboxypeptidase 2 Country-level Sales and Value Analysis
  1. 7.1 Global Glutamate Carboxypeptidase 2 Sales by Country: 2021 VS 2025 VS 2032
  2. 7.2 Global Glutamate Carboxypeptidase 2 Sales Value by Country: 2021 VS 2025 VS 2032
  3. 7.3 Global Glutamate Carboxypeptidase 2 Sales by Country (2021-2032)
  4. 7.3.1 Global Glutamate Carboxypeptidase 2 Sales by Country (2021-2026)
  5. 7.3.2 Global Glutamate Carboxypeptidase 2 Sales by Country (2027-2032)
  6. 7.4 Global Glutamate Carboxypeptidase 2 Sales Value by Country (2021-2032)
  7. 7.4.1 Global Glutamate Carboxypeptidase 2 Sales Value by Country (2021-2026)
  8. 7.4.2 Global Glutamate Carboxypeptidase 2 Sales Value by Country (2027-2032)
  9. 7.5 USA
  10. 7.5.1 USA Glutamate Carboxypeptidase 2 Sales Value Growth Rate (2021-2032)
  11. 7.5.2 USA Glutamate Carboxypeptidase 2 Sales Value Share by Type, 2025 VS 2032
  12. 7.5.3 USA Glutamate Carboxypeptidase 2 Sales Value Share by Application, 2025 VS 2032
  13. 7.6 Canada
  14. 7.6.1 Canada Glutamate Carboxypeptidase 2 Sales Value Growth Rate (2021-2032)
  15. 7.6.2 Canada Glutamate Carboxypeptidase 2 Sales Value Share by Type, 2025 VS 2032
  16. 7.6.3 Canada Glutamate Carboxypeptidase 2 Sales Value Share by Application, 2025 VS 2032
  17. 7.7 Mexico
  18. 7.6.1 Mexico Glutamate Carboxypeptidase 2 Sales Value Growth Rate (2021-2032)
  19. 7.6.2 Mexico Glutamate Carboxypeptidase 2 Sales Value Share by Type, 2025 VS 2032
  20. 7.6.3 Mexico Glutamate Carboxypeptidase 2 Sales Value Share by Application, 2025 VS 2032
  21. 7.8 Germany
  22. 7.8.1 Germany Glutamate Carboxypeptidase 2 Sales Value Growth Rate (2021-2032)
  23. 7.8.2 Germany Glutamate Carboxypeptidase 2 Sales Value Share by Type, 2025 VS 2032
  24. 7.8.3 Germany Glutamate Carboxypeptidase 2 Sales Value Share by Application, 2025 VS 2032
  25. 7.9 France
  26. 7.9.1 France Glutamate Carboxypeptidase 2 Sales Value Growth Rate (2021-2032)
  27. 7.9.2 France Glutamate Carboxypeptidase 2 Sales Value Share by Type, 2025 VS 2032
  28. 7.9.3 France Glutamate Carboxypeptidase 2 Sales Value Share by Application, 2025 VS 2032
  29. 7.10 U.K.
  30. 7.10.1 U.K. Glutamate Carboxypeptidase 2 Sales Value Growth Rate (2021-2032)
  31. 7.10.2 U.K. Glutamate Carboxypeptidase 2 Sales Value Share by Type, 2025 VS 2032
  32. 7.10.3 U.K. Glutamate Carboxypeptidase 2 Sales Value Share by Application, 2025 VS 2032
  33. 7.11 Italy
  34. 7.11.1 Italy Glutamate Carboxypeptidase 2 Sales Value Growth Rate (2021-2032)
  35. 7.11.2 Italy Glutamate Carboxypeptidase 2 Sales Value Share by Type, 2025 VS 2032
  36. 7.11.3 Italy Glutamate Carboxypeptidase 2 Sales Value Share by Application, 2025 VS 2032
  37. 7.12 Spain
  38. 7.12.1 Spain Glutamate Carboxypeptidase 2 Sales Value Growth Rate (2021-2032)
  39. 7.12.2 Spain Glutamate Carboxypeptidase 2 Sales Value Share by Type, 2025 VS 2032
  40. 7.12.3 Spain Glutamate Carboxypeptidase 2 Sales Value Share by Application, 2025 VS 2032
  41. 7.13 Russia
  42. 7.13.1 Russia Glutamate Carboxypeptidase 2 Sales Value Growth Rate (2021-2032)
  43. 7.13.2 Russia Glutamate Carboxypeptidase 2 Sales Value Share by Type, 2025 VS 2032
  44. 7.13.3 Russia Glutamate Carboxypeptidase 2 Sales Value Share by Application, 2025 VS 2032
  45. 7.14 Netherlands
  46. 7.14.1 Netherlands Glutamate Carboxypeptidase 2 Sales Value Growth Rate (2021-2032)
  47. 7.14.2 Netherlands Glutamate Carboxypeptidase 2 Sales Value Share by Type, 2025 VS 2032
  48. 7.14.3 Netherlands Glutamate Carboxypeptidase 2 Sales Value Share by Application, 2025 VS 2032
  49. 7.15 Nordic Countries
  50. 7.15.1 Nordic Countries Glutamate Carboxypeptidase 2 Sales Value Growth Rate (2021-2032)
  51. 7.15.2 Nordic Countries Glutamate Carboxypeptidase 2 Sales Value Share by Type, 2025 VS 2032
  52. 7.15.3 Nordic Countries Glutamate Carboxypeptidase 2 Sales Value Share by Application, 2025 VS 2032
  53. 7.16 China
  54. 7.16.1 China Glutamate Carboxypeptidase 2 Sales Value Growth Rate (2021-2032)
  55. 7.16.2 China Glutamate Carboxypeptidase 2 Sales Value Share by Type, 2025 VS 2032
  56. 7.16.3 China Glutamate Carboxypeptidase 2 Sales Value Share by Application, 2025 VS 2032
  57. 7.17 Japan
  58. 7.17.1 Japan Glutamate Carboxypeptidase 2 Sales Value Growth Rate (2021-2032)
  59. 7.17.2 Japan Glutamate Carboxypeptidase 2 Sales Value Share by Type, 2025 VS 2032
  60. 7.17.3 Japan Glutamate Carboxypeptidase 2 Sales Value Share by Application, 2025 VS 2032
  61. 7.18 South Korea
  62. 7.18.1 South Korea Glutamate Carboxypeptidase 2 Sales Value Growth Rate (2021-2032)
  63. 7.18.2 South Korea Glutamate Carboxypeptidase 2 Sales Value Share by Type, 2025 VS 2032
  64. 7.18.3 South Korea Glutamate Carboxypeptidase 2 Sales Value Share by Application, 2025 VS 2032
  65. 7.19 India
  66. 7.19.1 India Glutamate Carboxypeptidase 2 Sales Value Growth Rate (2021-2032)
  67. 7.19.2 India Glutamate Carboxypeptidase 2 Sales Value Share by Type, 2025 VS 2032
  68. 7.19.3 India Glutamate Carboxypeptidase 2 Sales Value Share by Application, 2025 VS 2032
  69. 7.20 Australia
  70. 7.20.1 Australia Glutamate Carboxypeptidase 2 Sales Value Growth Rate (2021-2032)
  71. 7.20.2 Australia Glutamate Carboxypeptidase 2 Sales Value Share by Type, 2025 VS 2032
  72. 7.20.3 Australia Glutamate Carboxypeptidase 2 Sales Value Share by Application, 2025 VS 2032
  73. 7.21 Southeast Asia
  74. 7.21.1 Southeast Asia Glutamate Carboxypeptidase 2 Sales Value Growth Rate (2021-2032)
  75. 7.21.2 Southeast Asia Glutamate Carboxypeptidase 2 Sales Value Share by Type, 2025 VS 2032
  76. 7.21.3 Southeast Asia Glutamate Carboxypeptidase 2 Sales Value Share by Application, 2025 VS 2032
  77. 7.22 Brazil
  78. 7.22.1 Brazil Glutamate Carboxypeptidase 2 Sales Value Growth Rate (2021-2032)
  79. 7.22.2 Brazil Glutamate Carboxypeptidase 2 Sales Value Share by Type, 2025 VS 2032
  80. 7.22.3 Brazil Glutamate Carboxypeptidase 2 Sales Value Share by Application, 2025 VS 2032
  81. 7.23 Argentina
  82. 7.23.1 Argentina Glutamate Carboxypeptidase 2 Sales Value Growth Rate (2021-2032)
  83. 7.23.2 Argentina Glutamate Carboxypeptidase 2 Sales Value Share by Type, 2025 VS 2032
  84. 7.23.3 Argentina Glutamate Carboxypeptidase 2 Sales Value Share by Application, 2025 VS 2032
  85. 7.24 Chile
  86. 7.24.1 Chile Glutamate Carboxypeptidase 2 Sales Value Growth Rate (2021-2032)
  87. 7.24.2 Chile Glutamate Carboxypeptidase 2 Sales Value Share by Type, 2025 VS 2032
  88. 7.24.3 Chile Glutamate Carboxypeptidase 2 Sales Value Share by Application, 2025 VS 2032
  89. 7.25 Colombia
  90. 7.25.1 Colombia Glutamate Carboxypeptidase 2 Sales Value Growth Rate (2021-2032)
  91. 7.25.2 Colombia Glutamate Carboxypeptidase 2 Sales Value Share by Type, 2025 VS 2032
  92. 7.25.3 Colombia Glutamate Carboxypeptidase 2 Sales Value Share by Application, 2025 VS 2032
  93. 7.26 Peru
  94. 7.26.1 Peru Glutamate Carboxypeptidase 2 Sales Value Growth Rate (2021-2032)
  95. 7.26.2 Peru Glutamate Carboxypeptidase 2 Sales Value Share by Type, 2025 VS 2032
  96. 7.26.3 Peru Glutamate Carboxypeptidase 2 Sales Value Share by Application, 2025 VS 2032
  97. 7.27 Saudi Arabia
  98. 7.27.1 Saudi Arabia Glutamate Carboxypeptidase 2 Sales Value Growth Rate (2021-2032)
  99. 7.27.2 Saudi Arabia Glutamate Carboxypeptidase 2 Sales Value Share by Type, 2025 VS 2032
  100. 7.27.3 Saudi Arabia Glutamate Carboxypeptidase 2 Sales Value Share by Application, 2025 VS 2032
  101. 7.28 Israel
  102. 7.28.1 Israel Glutamate Carboxypeptidase 2 Sales Value Growth Rate (2021-2032)
  103. 7.28.2 Israel Glutamate Carboxypeptidase 2 Sales Value Share by Type, 2025 VS 2032
  104. 7.28.3 Israel Glutamate Carboxypeptidase 2 Sales Value Share by Application, 2025 VS 2032
  105. 7.29 UAE
  106. 7.29.1 UAE Glutamate Carboxypeptidase 2 Sales Value Growth Rate (2021-2032)
  107. 7.29.2 UAE Glutamate Carboxypeptidase 2 Sales Value Share by Type, 2025 VS 2032
  108. 7.29.3 UAE Glutamate Carboxypeptidase 2 Sales Value Share by Application, 2025 VS 2032
  109. 7.30 Turkey
  110. 7.30.1 Turkey Glutamate Carboxypeptidase 2 Sales Value Growth Rate (2021-2032)
  111. 7.30.2 Turkey Glutamate Carboxypeptidase 2 Sales Value Share by Type, 2025 VS 2032
  112. 7.30.3 Turkey Glutamate Carboxypeptidase 2 Sales Value Share by Application, 2025 VS 2032
  113. 7.31 Iran
  114. 7.31.1 Iran Glutamate Carboxypeptidase 2 Sales Value Growth Rate (2021-2032)
  115. 7.31.2 Iran Glutamate Carboxypeptidase 2 Sales Value Share by Type, 2025 VS 2032
  116. 7.31.3 Iran Glutamate Carboxypeptidase 2 Sales Value Share by Application, 2025 VS 2032
  117. 7.32 Egypt
  118. 7.32.1 Egypt Glutamate Carboxypeptidase 2 Sales Value Growth Rate (2021-2032)
  119. 7.32.2 Egypt Glutamate Carboxypeptidase 2 Sales Value Share by Type, 2025 VS 2032
  120. 7.32.3 Egypt Glutamate Carboxypeptidase 2 Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
  1. 8.1 Eisai Co Ltd
  2. 8.1.1 Eisai Co Ltd Company Information
  3. 8.1.2 Eisai Co Ltd Business Overview
  4. 8.1.3 Eisai Co Ltd Glutamate Carboxypeptidase 2 Sales, Value and Gross Margin (2021-2026)
  5. 8.1.4 Eisai Co Ltd Glutamate Carboxypeptidase 2 Product Portfolio
  6. 8.1.5 Eisai Co Ltd Recent Developments
  7. 8.2 Inovio Pharmaceuticals Inc
  8. 8.2.1 Inovio Pharmaceuticals Inc Company Information
  9. 8.2.2 Inovio Pharmaceuticals Inc Business Overview
  10. 8.2.3 Inovio Pharmaceuticals Inc Glutamate Carboxypeptidase 2 Sales, Value and Gross Margin (2021-2026)
  11. 8.2.4 Inovio Pharmaceuticals Inc Glutamate Carboxypeptidase 2 Product Portfolio
  12. 8.2.5 Inovio Pharmaceuticals Inc Recent Developments
  13. 8.3 Crescendo Biologics Ltd
  14. 8.3.1 Crescendo Biologics Ltd Company Information
  15. 8.3.2 Crescendo Biologics Ltd Business Overview
  16. 8.3.3 Crescendo Biologics Ltd Glutamate Carboxypeptidase 2 Sales, Value and Gross Margin (2021-2026)
  17. 8.3.4 Crescendo Biologics Ltd Glutamate Carboxypeptidase 2 Product Portfolio
  18. 8.3.5 Crescendo Biologics Ltd Recent Developments
  19. 8.4 Cerecor Inc
  20. 8.4.1 Cerecor Inc Company Information
  21. 8.4.2 Cerecor Inc Business Overview
  22. 8.4.3 Cerecor Inc Glutamate Carboxypeptidase 2 Sales, Value and Gross Margin (2021-2026)
  23. 8.4.4 Cerecor Inc Glutamate Carboxypeptidase 2 Product Portfolio
  24. 8.4.5 Cerecor Inc Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Glutamate Carboxypeptidase 2 Value Chain Analysis
  2. 9.1.1 Glutamate Carboxypeptidase 2 Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Glutamate Carboxypeptidase 2 Sales Mode & Process
  6. 9.2 Glutamate Carboxypeptidase 2 Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Glutamate Carboxypeptidase 2 Distributors
  9. 9.2.3 Glutamate Carboxypeptidase 2 Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,250USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research, Inc.
    Talk to an analyst